BioSpace Clinical Catch-Up: July 13-17 (Algernon Pharmaceuticals Inc.)



Algernon Pharmaceuticals completed its clinical trial agreement with Westchester Research Center at Westchester General Hospital in Miami, Florida, for its multinational Phase IIb/III trial of NP-120 (ifenprodil) for COVID-19. The trial is expected to start after July 20.


READ THE FULL ARTICLE HERE


SOURCE

Recent Posts

See All